Prostate Care Limited

Prostate Care Limited Precision Diagnostics and Nuanced Care - bringing innovation in prostate cancer testing & treatment

Nuada Medical is a centre of excellence and innovation in precision diagnostics and nuanced care for men with prostate disease. We provide the technology, expertise and support to Urologists and hospitals who wish to offer their patients a noninvasive precision-led pathway of diagnostics and care - starting with mpMRI imaging and reporting through to MR/US biopsy to HIFU treatment.

25/08/2023

The PRESERVE study of the NanoKnife System for the ablation of prostate tissue is exploring the focal treatment in patients with intermediate-risk prostate cancer.

25/08/2023

yesterday's encouraging news on MRI screening for prostate cancer brought out some devastating examples of how men are currently diagnosed

25/08/2023

Two-thirds of men with a positive screening MRI for prostate cancer had PSA levels below 3 ng/mL and 91 percent of these men had clinically significant prostate cancer, according to newly published research.

10/06/2023

Mr Marc Laniado, consultant with The Focal Therapy Clinic discusses Active Surveillance and making informed decisions for treatment.

06/05/2023

Prostate cancer is the second most common cancer in American men, with an estimated 288,000 new diagnoses expected in 2023.

06/05/2023

The majority of the initial seminal cancer treatment trials during the 1970s and later on focused on clinical efficacy and clinician-assessed harms. Patient-reported outcome measures (PROMs) including health-related quality of life (QoL) were rarely collected. Even once they started to be

06/05/2023

AUA 2023 PSA screening, BAUS/BJUI/USANZ, Early Detection of Prostate Cancer, overdiagnosis and overtreatment of prostate cancer.

06/05/2023

Matt Cooperberg interviews Tyler Seibert, a radiation oncologist and assistant professor at UC San Diego. They focus on the use of MRI for localized prostate cancer, which has drastically changed the diagnostic pathway for prostate cancer in the last decade. However, the variability in the way the M...

24/04/2023

Focal therapy for localized prostate cancer is well accepted by patients, with a satisfaction rate of > 80%. Higher prostate-specific antigen at nadir, presence of cancer on follow-up biopsy, bothersome postoperative urinary symptoms, and impotence after focal therapy were independent predictors of....

24/04/2023

“As an oncologist, patients rely on us to convey to them the relative risks and benefits of a treatment. And I think we should consider time toxicity more explicitly in these conversations.”

24/04/2023

An overview of the various issues older patients experience in prostate cancer diagnosis and treatment.

15/04/2023

We propose FT to be an effective management option for the older or comorbid patient who is unsuitable for or not willing to undergo radical treatment.

Address

London

Telephone

+442070368850

Website

Alerts

Be the first to know and let us send you an email when Prostate Care Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Prostate Care Limited:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category